Eczema Trial, Recruiting NCT07444801 Sponsor: University Hospital Schleswig-Holstein Condition: Eczema
Back to Eczema

Eczema Trial, Recruiting

NCT07444801
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You must be able to understand the study information, communicate with the research team, and sign a written consent form before taking part.
  • You must be at least 18 years old when you join the study.
  • You must be someone for whom a doctor has already decided — independently of this study — that treatment with tralokinumab is the right course of action, following approved guidelines.
  • You must have been diagnosed with moderate-to-severe eczema (atopic dermatitis) that affects the genital area, and be eligible for a systemic (whole-body) treatment according to local guidelines.

Who may not be able to join:

  • Anyone who does not meet the approved safety requirements for tralokinumab (the medication used in this study) will not be eligible (confirm with trial site).
  • Anyone who is not able to fully understand and agree to the consent process cannot participate.
  • Anyone who is currently taking part in another clinical trial involving an experimental treatment cannot join (though participation in non-interventional studies or registries is generally allowed).
  • Women who are currently pregnant or breastfeeding are not able to take part.
  • Anyone whose eczema does not affect the genital area is not eligible.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +4945150041626

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University Hospital Schleswig-Holstein
Registry
ClinicalTrials.gov
Start date
20 October 2025
Est. completion
31 October 2027

Where this trial is recruiting

🇩🇪 Germany

Primary endpoints

Genital-Numerical Rating Scale

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov